Pasar al contenido principal

Refine your results

Filtros
Buscar
Include spaces in matter number if applicable. Ex.: 182 3125
Fecha
Displaying 1181 - 1200 of 45321
Cases and Proceedings
Commissioner Statements

Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding the Notice of Proposed Rulemaking on the Negative Option Rule

Date
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner;
Alvaro Bedoya, Former Commissioner
Matter Number
P064202
HSR Informal Interpretations

2303004 Informal Interpretation

… RE: Question Re: 802.10(b) It’s the basic percentage of both entities. From: [Redacted] Sent: Wednesday, March … 802.10(b) All, We have a question regarding the application of Rule 802.10(b)(2)(i) in connection with the conversion of a limited partnership to a corporation and would appreciate your …
Date
Rule
801.10
It’s the basic percentage of both entities.
HSR Informal Interpretations

2303006 Informal Interpretation

… [Redacted] Cc: HSRHelp <HSRHelp@ftc.gov> Subject: FW: Sale of MSRs We agree. From: [Redacted] Sent: Wednesday, March … (US & Canada) To: HSRHelp <HSRHelp@ftc.gov> Subject: Sale of MSRs I am writing to seek your view regarding whether the … 7A(c)(1) as a sale in the ordinary course of business. Party A currently is in the mortgage lending and servicing …
Date
Rule
7A(c)(1)
We agree.
Amicus Briefs

Sage Chemical, Inc. et al. v. Supernus Pharmaceuticals, Inc. et al.

… amicus brief with the U.S. District Court for the District of Delaware in the case of  Sage Chemical, Inc. et al. v. Supernus Pharmaceuticals, …
Date
Federal Court
District of Delaware
The Federal Trade Commission filed an amicus brief with the U.S. District Court for the District of Delaware in the case of Sage Chemical, Inc. et al. v. Supernus Pharmaceuticals, Inc. et al. The...
Cases and Proceedings

Dalal A. Akoury d/b/a AWAREmed, et al., U.S. v.

In March 2023, the FTC took action under the Opioid Addiction Recovery Fraud Prevention Act, suing Dr. Dalal A. Akoury and a set of companies she controls that operate as AWAREmed Health & Wellness Resource Center, a medical clinic, for making a wide range of false or unsupported claims for addiction treatment services, cancer treatment services, and the treatment of other serious conditions. The proposed order settling the Commission’s complaint bars Dr. Akoury and her AWAREmed clinic from making such unsupported claims and requires her to pay a $100,000 civil penalty.

 

Type of Action
Federal
Last Updated
FTC Matter/File Number
2123039
Docket Number
2:23-CV-00026
Case Status
Pending
Displaying 1181 - 1200 of 45321
Return to top